• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球胃癌的变化趋势

Changing Trends in Stomach Cancer Throughout the World.

作者信息

Balakrishnan Maya, George Rollin, Sharma Ashish, Graham David Y

机构信息

Department of Medicine, Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, TX, USA.

Michael E. DeBakey Veterans Affairs Medical Center, RM 3A-318B (111D), 2002 Holcombe Boulevard, Houston, TX, 77030, USA.

出版信息

Curr Gastroenterol Rep. 2017 Aug;19(8):36. doi: 10.1007/s11894-017-0575-8.

DOI:10.1007/s11894-017-0575-8
PMID:28730504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6918953/
Abstract

PURPOSE OF REVIEW

The paper aims to discuss the global trends in gastric cancer incidence in relation to important factors involved in the pathogenesis of gastric cancer.

RECENT FINDINGS

Despite a significant worldwide decline, gastric cancer remains a common cause of cancer death. The decline has been multifactorial and preceded the fall in Helicobacter pylori prevalence. The initial decline was associated with changes in food preservation and availability, especially of fresh fruits and vegetables, followed by a decline in the primary etiologic factor, H. pylori. Gastric cancer incidence remains high in East Asia, intermediate in Latin America, and low in developed countries. Significant racial/ethnic variability exists. The rapid decline in incidence in East Asia will continue as primary and secondary prevention strategies are implemented. The incidence in Latin America is unlikely to decline significantly over the next few decades given high H. pylori prevalence in the young. Ultimately, global H. pylori eradication will be needed to largely eliminate gastric cancer.

摘要

综述目的

本文旨在探讨胃癌发病率的全球趋势及其与胃癌发病机制中重要因素的关系。

最新研究结果

尽管全球范围内胃癌发病率显著下降,但它仍是癌症死亡的常见原因。这种下降是多因素导致的,且早于幽门螺杆菌感染率的下降。最初的下降与食物保存和供应的变化有关,尤其是新鲜水果和蔬菜,随后主要病因幽门螺杆菌的感染率也下降了。东亚地区胃癌发病率仍然很高,拉丁美洲处于中等水平,而发达国家则较低。存在显著的种族/民族差异。随着一级和二级预防策略的实施,东亚地区发病率的快速下降趋势将持续。鉴于年轻人中幽门螺杆菌感染率较高,拉丁美洲的发病率在未来几十年不太可能显著下降。最终,需要在全球范围内根除幽门螺杆菌,以大幅消除胃癌。

相似文献

1
Changing Trends in Stomach Cancer Throughout the World.全球胃癌的变化趋势
Curr Gastroenterol Rep. 2017 Aug;19(8):36. doi: 10.1007/s11894-017-0575-8.
2
Asia-Pacific consensus guidelines on gastric cancer prevention.《亚太地区胃癌预防共识指南》
J Gastroenterol Hepatol. 2008 Mar;23(3):351-65. doi: 10.1111/j.1440-1746.2008.05314.x.
3
Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.亚洲地区幽门螺杆菌感染和胃癌的流行病学。
J Gastroenterol Hepatol. 2010 Mar;25(3):479-86. doi: 10.1111/j.1440-1746.2009.06188.x.
4
Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.幽门螺杆菌感染和吸烟对中国胃癌发病率的影响:基于趋势和预测的人群水平分析。
Cancer Causes Control. 2009 Dec;20(10):2021-9. doi: 10.1007/s10552-009-9397-9.
5
Review article: Helicobacter pylori and gastric cancer--the clinicians'point of view.综述文章:幽门螺杆菌与胃癌——临床医生的观点
Aliment Pharmacol Ther. 2000 Oct;14 Suppl 3:48-54. doi: 10.1046/j.1365-2036.2000.00100.x.
6
Changing epidemiology of Helicobacter pylori in Asia.亚洲幽门螺杆菌流行病学的变化
J Dig Dis. 2008 Nov;9(4):186-9. doi: 10.1111/j.1751-2980.2008.00344.x.
7
The enigma of Helicobacter pylori infection and gastric cancer.幽门螺杆菌感染与胃癌之谜。
Indian J Gastroenterol. 2010 Jun;29(3):95-100. doi: 10.1007/s12664-010-0024-1. Epub 2010 Jun 29.
8
Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model.幽门螺杆菌和吸烟趋势对美国肠型非贲门胃腺癌发病率的贡献:一个微观模拟模型。
PLoS Med. 2013;10(5):e1001451. doi: 10.1371/journal.pmed.1001451. Epub 2013 May 21.
9
Helicobacter pylori as a risk factor for cancer.幽门螺杆菌作为癌症的一个风险因素。
Baillieres Clin Gastroenterol. 1995 Sep;9(3):563-82. doi: 10.1016/0950-3528(95)90049-7.
10
Epidemiology of gastric cancer and perspectives for prevention.胃癌流行病学与预防前景
Salud Publica Mex. 1997 Jul-Aug;39(4):318-30. doi: 10.1590/s0036-36341997000400010.

引用本文的文献

1
Epidemiological trends of early-onset gastrointestinal cancers from 1990 to 2021 and predictions for 2036: analysis from the global burden of disease study 2021.1990年至2021年早发性胃肠道癌症的流行病学趋势及2036年预测:来自2021年全球疾病负担研究的分析
Ann Med. 2025 Dec;57(1):2555518. doi: 10.1080/07853890.2025.2555518. Epub 2025 Sep 5.
2
Trends and Disparities in Mortality Due to Gastric Malignancies the United States: A Nationwide Analysis from 1999 to 2020.美国胃癌死亡率的趋势与差异:1999年至2020年的全国性分析
J Gastrointest Cancer. 2025 Aug 5;56(1):168. doi: 10.1007/s12029-025-01295-9.
3
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker- and Proton Pump Inhibitor-Based Bismuth Quadruple Therapy for Eradication: A Network Meta-Analysis.

本文引用的文献

1
Helicobacter pylori as an oncogenic pathogen, revisited.再探幽门螺杆菌作为致癌病原体的情况。
Expert Rev Mol Med. 2017 Mar 21;19:e4. doi: 10.1017/erm.2017.4.
2
Racial and Ethnic Minorities at Increased Risk for Gastric Cancer in a Regional US Population Study.美国一地区性人群研究显示,少数族裔罹患胃癌的风险更高。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):511-517. doi: 10.1016/j.cgh.2016.11.033. Epub 2016 Dec 9.
3
Changing epidemiology of Helicobacter pylori in Japan.日本幽门螺杆菌流行病学的变化
基于钾离子竞争性酸阻滞剂和质子泵抑制剂的铋剂四联疗法根除幽门螺杆菌的疗效和安全性比较:网状Meta分析
Gastro Hep Adv. 2025 May 16;4(9):100705. doi: 10.1016/j.gastha.2025.100705. eCollection 2025.
4
Diagnostic accuracy of 18F-FDG and 68 Ga-FAPi PET/CT for patients with gastric carcinoma: a systematic review and meta-analysis.18F-FDG和68Ga-FAPi PET/CT对胃癌患者的诊断准确性:一项系统评价和荟萃分析
Ann Nucl Med. 2025 Jul 11. doi: 10.1007/s12149-025-02082-z.
5
Impact of Pre-treatment Proteinuria Progression on the Risk of Increased Proteinuria During Ramucirumab Therapy.治疗前蛋白尿进展对雷莫西尤单抗治疗期间蛋白尿增加风险的影响。
Cancer Diagn Progn. 2025 Jun 30;5(4):437-452. doi: 10.21873/cdp.10457. eCollection 2025 Jul-Aug.
6
Trends in incidence and mortality of early-onset gastrointestinal cancers: a comprehensive study.早发性胃肠道癌症的发病率和死亡率趋势:一项综合研究。
BMC Gastroenterol. 2025 Jun 2;25(1):424. doi: 10.1186/s12876-025-04015-6.
7
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.瑞戈非尼联合伊立替康作为转移性胃食管腺癌的二线治疗:PRODIGE 58-UCGI35-REGIRI单癌种随机II期研究结果
ESMO Open. 2025 May;10(5):105096. doi: 10.1016/j.esmoop.2025.105096. Epub 2025 May 12.
8
Causal link between mental disorders and gastrointestinal diseases: a Mendelian randomization study.精神障碍与胃肠道疾病之间的因果关系:一项孟德尔随机化研究。
Front Endocrinol (Lausanne). 2025 Apr 22;16:1288619. doi: 10.3389/fendo.2025.1288619. eCollection 2025.
9
Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen?营养和炎症指标能否预测接受新辅助FLOT方案治疗的老年胃癌患者的反应?
Cancer Control. 2025 Jan-Dec;32:10732748251335367. doi: 10.1177/10732748251335367. Epub 2025 Apr 18.
10
Long-Term Exposure to Nitrate and Trihalomethanes in Drinking Water and Gastric Cancer: A Multicase-Control Study in Spain (MCC-Spain).饮用水中硝酸盐和三卤甲烷的长期暴露与胃癌:西班牙的一项多病例对照研究(MCC-西班牙)
Environ Health Perspect. 2025 May;133(5):57014. doi: 10.1289/EHP15039. Epub 2025 May 22.
Gastric Cancer. 2017 Mar;20(Suppl 1):3-7. doi: 10.1007/s10120-016-0658-5. Epub 2016 Oct 18.
4
Current Perspectives on Gastric Cancer.胃癌的当前观点
Gastroenterol Clin North Am. 2016 Sep;45(3):413-28. doi: 10.1016/j.gtc.2016.04.002.
5
An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence.对全球癌症负担数据(GLOBOCAN)方法在推算国家癌症发病率估计值方面的评估。
Bull World Health Organ. 2016 Mar 1;94(3):174-84. doi: 10.2471/BLT.15.164384. Epub 2016 Jan 28.
6
Screening and surveillance for gastric cancer in the United States: Is it needed?美国胃癌的筛查与监测:有必要吗?
Gastrointest Endosc. 2016 Jul;84(1):18-28. doi: 10.1016/j.gie.2016.02.028. Epub 2016 Mar 3.
7
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
8
Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations.大规模根除幽门螺杆菌以预防胃癌:理论与实践考量
Gut Liver. 2016 Jan;10(1):12-26. doi: 10.5009/gnl15091.
9
Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication.幽门螺杆菌感染患者及其根除后的胃癌风险
Gastroenterol Clin North Am. 2015 Sep;44(3):609-24. doi: 10.1016/j.gtc.2015.05.009. Epub 2015 Jul 7.
10
Kyoto global consensus report on Helicobacter pylori gastritis.《京都幽门螺杆菌胃炎全球共识报告》
Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252. Epub 2015 Jul 17.